Herbal Extract

Vietnam Tightens Herbal Extract Import Filing

Vietnam Tightens Herbal Extract Import Filing: learn how the new MOH rule, AI stability report, and 14-day testing window may delay customs clearance—and what importers and exporters should do now.
Time : Jul 03, 2026

On July 15, 2026, a new compliance requirement took effect for herbal extract imports into Vietnam. The change stems from the Ministry of Health (MOH) Circular No. 28/2026/TT-BYT, issued in the early hours of July 2, and it directly affects shipments declared under the HS label “Herbal Extract” (2938.90.90). For exporters, importers, and supply chain teams handling plant extracts, the immediate issue is not only documentation completeness but also lead-time control, because the required AI-based stability prediction report adds a testing step that can materially delay customs clearance.

What the new filing requirement confirms

According to the information provided, Vietnam’s MOH revised the import list for herbal extracts and introduced a mandatory AI stability prediction report for all plant extracts declared for import under “Herbal Extract” with HS code 2938.90.90.

The report must be issued by a laboratory recognized by Vietnam and must follow ISO/IEC 23053:2025. The required assessment covers three dimensions: thermal sensitivity, photodegradation kinetics, and pH migration.

The notice referenced is Circular No. 28/2026/TT-BYT, released by the MOH on July 2, 2026, with implementation starting on July 15, 2026. The provided information also states that Chinese exporters need to reserve a 14-day testing period; otherwise, customs clearance delays may exceed 10 working days.

Where the impact is likely to be felt first

Export operations face a tighter pre-shipment timeline

From an industry perspective, direct trading companies shipping plant extracts to Vietnam are likely to feel the impact first. The reason is straightforward: the new report is not an optional technical appendix but a required import document for the specified declaration category. This shifts part of the compliance burden earlier in the shipment cycle, especially in booking, document preparation, and export scheduling.

What deserves closer attention is the connection between testing lead time and delivery commitments. If the 14-day preparation window is not built into the shipment plan, the risk moves quickly from a paperwork issue to a fulfillment issue.

Import-side procurement and customs coordination become more sensitive

Importers and procurement teams in Vietnam may also face immediate operational pressure. Analysis shows that once a report issued by a Vietnam-recognized laboratory becomes mandatory, document verification and coordination with customs-facing teams become more time-sensitive. The effect is likely to be most visible in order confirmation, expected arrival planning, and communication with upstream suppliers.

For buyers, the practical question is whether suppliers can provide compliant reports in time, not merely whether the product itself is ready to ship.

Testing and compliance service providers move closer to the transaction flow

Supply chain service providers, laboratories, and compliance support teams may become more central to execution under this rule. Observably, the requirement is specific in both issuer qualification and report content, which means the report cannot be treated as a generic quality document. The business impact is likely to concentrate around laboratory recognition status, report acceptance, and handoff timing between testing and customs documentation.

This does not by itself confirm a broader regulatory redesign, but it does indicate a more document-sensitive import process for the affected product category.

What companies should watch now

Check product classification and declaration scope carefully

The first practical issue is whether a shipment is being declared under “Herbal Extract” with HS code 2938.90.90. Since the requirement is tied to that declaration category, companies should review classification practice and make sure internal teams, brokers, and counterparties are aligned on what falls within scope.

Build the testing window into contract and shipment planning

The provided information states that Chinese exporters should reserve 14 days for testing. In practical terms, this means delivery calendars, production release, and shipment booking may need to reflect a longer compliance lead time. Where delivery dates are tight, companies may need earlier document cutoffs and clearer responsibility allocation between supplier and importer.

Focus on report issuer qualification, not only report content

Another operational priority is the requirement that the report be issued by a laboratory recognized by Vietnam. Analysis shows that document acceptance risk may arise not only from missing test dimensions but also from whether the issuing laboratory meets the recognition condition stated in the rule.

For companies already shipping into Vietnam, this makes supplier qualification and laboratory coordination a near-term checkpoint rather than a secondary compliance detail.

Separate policy wording from execution practice

What deserves closer attention is the difference between a rule taking effect and the way it is enforced in day-to-day clearance. The rule is already effective from July 15, 2026, but companies should continue tracking how consistently the documentation requirement is applied in actual import processing. That distinction matters for shipment prioritization, customer communication, and contingency planning.

Why this looks like more than a short-lived document update

Analysis shows that this development is best read as a targeted compliance signal rather than a routine paperwork revision. The introduction of an AI stability prediction report, paired with a named standard and three defined testing dimensions, suggests a more technical review threshold for the covered herbal extract imports.

At the same time, it would be premature to treat this alone as proof of a wider regulatory expansion beyond the scope provided here. It is more appropriate to understand this as an immediate operational change with possible longer-term significance, especially for businesses relying on repeat shipments under the same HS declaration.

Observably, the near-term consequence is clear: document readiness and testing lead time now matter more in shipment execution. The longer-term implication still requires continued monitoring.

How to read the significance at this stage

At this stage, the update should be understood primarily as an active compliance change with direct customs and scheduling consequences for herbal extract trade into Vietnam. It is not just a policy headline; it affects documentation sequence, testing preparation, and delivery timing for the covered category.

From an industry perspective, the most balanced reading is that this is an immediate short-term operating adjustment and a longer-term regulatory signal worth watching. The strongest current takeaway is not market direction but execution discipline: companies involved in affected shipments need to align classification, testing, and documentation earlier than before.

Basis of this article and what still needs verification

This article is based on the user-provided news title, event date, and event summary. The information refers to Vietnam MOH Circular No. 28/2026/TT-BYT, the July 15, 2026 effective date, the requirement for an AI stability prediction report under ISO/IEC 23053:2025, the three required assessment dimensions, and the stated 14-day testing lead time with possible customs delays exceeding 10 working days.

For this type of industry update, source categories typically relevant include official government notices, enterprise compliance notices, industry association updates, authoritative media reporting, and standard-setting organization documents. A specific official source link was not provided in the input, so the exact publication text and any later implementation clarifications still need ongoing verification.

Further monitoring should focus on any follow-up official wording, execution details in customs practice, and whether additional clarification emerges around laboratory recognition and document review expectations.

Next:No more content

Related News